# Hemastatx jobs and careers

> 0 open roles at Hemastatx as of October 23, 2026. Source: https://www.thejobsmap.com/company/hemastatx

Hemastatx is committed to bringing scientific innovation to patients with severe and underserved bleeding disorders, aiming to become a leader in hematology. Founded in 2025 as a spin-off from KU Leuven, Hemastatx builds on over a decade of pioneering research in hemostasis at the Laboratory for Thrombosis Research, led by Prof. dr. Karen Vanhoorelbeke. Our first lead program, HMX-001, is a proprietary monoclonal antibody designed to present bleeding in patients with von Willebrand factor (VWF)-related disorders by targeting the underlying biological mechanism. The program is supported by a robust preclinical data package and broad patent protection. With headquarters in Switzerland and an R&D hub in Belgium, Hemastatx is strategically positioned within two of Europe’s leading biotech ecosystems.

## Key facts

| | |
|---|---|
| Open roles | 0 |
| Headquarters | Switzerland |
| Employees | 1 to 10 |
| Website | https://hemastatx.com |

## Common questions

### Is Hemastatx hiring right now?

Hemastatx has no open roles listed as of October 23, 2026. Roles appear here as soon as they are posted on Hemastatx's careers site.

### Where is Hemastatx headquartered?

Hemastatx is headquartered in Switzerland.

### How do I apply for a job at Hemastatx?

Pick a role on Hemastatx's TheJobsMap page and select Apply. Every listing links to the original posting on Hemastatx's own careers site, so you apply directly with the employer.